Workshop · Dec 14–16, 2026
Grant
Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease Registry
Pfizer
- , Add deadline: choose a calendar
- Germany
- Institution applies
- Rheumatology, Clinical Neurology and
About
German teams can establish or expand a longitudinal registry to study treatment patterns, safety, disease burden and patient outcomes in idiopathic inflammatory myopathies. Proposals should link clinician- and patient-reported data across specialist and routine care.
Topics
- Idiopathic Inflammatory Myopathies, search World Wide
- Real-World Evidence, search World Wide
- German Disease Registry, search World Wide
- longitudinal registry, search World Wide
- treatment patterns, search World Wide
- safety, search World Wide
- disease burden, search World Wide
- patient outcomes, search World Wide
- patient-reported data, search World Wide
Eligibility
Covers: Up to EUR 350,000 over three years. First-year funding is limited to EUR 100,000.
The geographic scope of the call is DE.
The institution and medically qualified principal investigator must be based in Germany. The principal investigator must be an employee or contractor of the requesting organization.
Source: cdn.pfizer.com